Resultados de la búsqueda 121-130 of 15102 for cefpodoxime

  1. Médicos y departamentos

    Loscalzo J, et al., eds. Staphylococcal infections. In: Harrison's Principles of Internal Medicine. 21st ed.

  2. Enfermedades infecciosas - Ensayos clínicos - Mayo Clinic

    Immunity to Hepatitis B through vaccination in patients with inflammatory bowel disease and chronic liver disease is crucial due to high risk of morbidity. Part ...

  3. Enfermedades infecciosas - Ensayos clínicos - Mayo Clinic

    The purposes of this study are to determine if patients treated with fluoroquinolone (FQ) antibiotics have depletion of mitochondrial DNA (mtDNA) in buccal ...

  4. Bispecific antibody therapy

    Bispecific antibody therapy uses medicines that target diseases in two ways at the same time. It uses specially designed, lab-made proteins called bispecific ...

  5. Clínica de hipertensión - Panorama general - Mayo Clinic

    The Hypertension Clinic provides specialized care for adults whose blood pressure stays high despite treatment or has been hard to control over time.

  6. Enfermedades de trasmisión sexual

    Adamson PC, et al. Point-of-care testing for sexually transmitted infections: A review of recent developments. Archives of Pathology and Laboratory Medicine ...

  7. Hematología - Ensayos clínicos - Mayo Clinic

    The purpose of this study is to compare the effectiveness of rituximab to mosunetuzumab in treating patients with follicular lymphoma with a low tumor burden.

  8. Enfermedades de trasmisión sexual

    Adamson PC, et al. Point-of-care testing for sexually transmitted infections: A review of recent developments. Archives of Pathology and Laboratory Medicine ...

  9. Hematología - Ensayos clínicos - Mayo Clinic

    The purpose of this study is to compare the effectiveness of rituximab to mosunetuzumab in treating patients with follicular lymphoma with a low tumor burden.

  10. Hematología - Ensayos clínicos - Mayo Clinic

    The purpose of this study is to compare the effectiveness of rituximab to mosunetuzumab in treating patients with follicular lymphoma with a low tumor burden.